Abstract
The paucity of biomarkers for malignant obstructive jaundice results in formidable morbidity and mortality rates. Therefore, alternative diagnostic measures are required for improved clinical interpretation and better peri-operative management of patients. In the present study, 1H NMR-based metabolomic approach has been applied to investigate serum and bile based metabolic biomarkers in benign and malignant causes of obstructive jaundice (OBJ). Serum and bile specimens from benign OBJ patients (n = 28), malignant OBJ patients (n = 36) and serum of healthy controls (n = 57) were analysed by 1H NMR spectroscopy. Quantitation of eight serum metabolites (isobutyrate, lactate, alanine, acetone, glutamine, creatine, threonine and 1-methylhistidine) was carried out. A newer and rapid single step NMR based semi-quantitative ratio analysis of serum total cholesterol (tCho), cholesterol (Chol) and cholesterol ester (CE) were performed in deuterated dimethyl sulfoxide-d6. In bile, total bile acids, cholesterol, phosphatidylcholine, glycerophosphatidylcholine and urea were quantified. The effect of benign and malignant OBJ on small metabolites and lipids were statistically analysed by Mann–Whitney U test and multivariate discriminant function analysis. It was found that malignancy could be differentiated from benign cases of OBJ with a correct classification of 85.7 % when eight serum metabolites in combination with ratios of serum cholesterol were analysed. Significant alterations in serum tCho, Chol, CE and serum metabolites may have potential for early and differential non-invasive diagnosis of malignant and benign OBJ cases. It will further augment the novel insights of local and systemic effects in OBJ patients.
Similar content being viewed by others
Abbreviations
- OBJ:
-
Obstructive jaundice
- Chol:
-
Cholesterol
- CE:
-
Cholesterol esters
- tCho:
-
Total cholesterol
- PtdCho:
-
Phosphatidyl choline
- DFA:
-
Discriminant function analysis
References
Alvaro, D. (2009). Serum and bile biomarkers for cholangiocarcinoma. Current Opinion in Gastroenterology, 25(3), 279–284.
Attili, A. F., Capocaccia, R., Carulli, N., Festi, D., Roda, E., Barbara, L., et al. (1997). Factors associated with gallstone disease in the MICOL experience. Multicenter Italian study on epidemiology of cholelithiasis. Hepatology, 26(4), 809–818. doi:10.1002/hep.510260401.
Bala, L., Tripathi, P., Bhatt, G., Das, K., Roy, R., Choudhuri, G., et al. (2009). (1)H and (31)P NMR studies indicate reduced bile constituents in patients with biliary obstruction and infection. NMR in Biomedicine, 22(2), 220–228. doi:10.1002/nbm.1308.
Bala, L., Tripathi, P., Choudhuri, G., & Khetrapal, C. L. (2011). Restoration of hepatocytes function following decompression therapy in extrahepatic biliary obstructed patients: metabolite profiling of bile by NMR. Journal of Pharmaceutical and Biomedical Analysis, 56(1), 54–63. doi:10.1016/j.jpba.2011.04.010.
Bathe, O. F., Shaykhutdinov, R., Kopciuk, K., Weljie, A. M., McKay, A., Sutherland, F. R., et al. (2011). Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiology, Biomarkers and Prevention, 20(1), 140–147. doi:10.1158/1055-9965.epi-10-0712.
Buchwald, H. (1992). Cholesterol inhibition, cancer, and chemotherapy. The Lancet, 339(8802), 1154–1156. doi:10.1016/0140-6736(92)90744-n.
Carpelan-Holmström, M., Louhimo, J., Stenman, U. H., Alfthan, H., & Haglund, C. (2002). CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer research, 22(4), 2311–2316.
Donner, M., & Keppler, D. (2001). Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology, 34(2), 351–359.
Duarte, I. F., Legido-Quigley, C., Parker, D. A., Swann, J. R., Spraul, M., Braumann, U., et al. (2009). Identification of metabolites in human hepatic bile using 800 MHz 1H NMR spectroscopy, HPLC-NMR/MS and UPLC-MS. Molecular BioSystems, 5(2), 180–190. doi:10.1039/b814426e.
Folch, J., Lees, M., & Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipides from animal tissues. The Journal of biological chemistry, 226(1), 497–509.
Garcea, G., Ngu, W., Neal, C. P., Dennison, A. R., & Berry, D. P. (2011). Bilirubin levels predict malignancy in patients with obstructive jaundice. HPB: The Official Journal of the International Hepato Pancreato Biliary Association, 13(6), 426–430.
Geier, A., Wagner, M., Dietrich, C. G., & Trauner, M. (2007). Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochimica et Biophysica Acta, 1773(3), 283–308.
Ghimire, P., Yogi, N., & Shrestha, B. B. (2011). Incidence of incidental carcinoma gall bladder in cases of routine cholecystectomy. Kathmandu Univ Med J (KUMJ), 9(34), 3–6.
Harry, D. S., Day, R. C., Owen, J. S., Agorastos, J., Foo, A. Y., & McIntyre, N. (1978). Plasma Lecithin:Cholesterol acyltransferase activity and the lipoprotein abnormalities of liver disease. The Scandinavian Journal of Clinical and Laboratory Investigation, 38(Supplement), 223–227.
Hayat, J. O., Loew, C. J., Asrress, K. N., McIntyre, A. S., & Gorard, D. A. (2005). Contrasting liver function test patterns in obstructive jaundice due to biliary structures and stones. QJM: An International Journal of Medicine, 98(1), 35–40.
Ijare, O. B., Bezabeh, T., Albiin, N., Arnelo, U., Bergquist, A., Lindberg, B., et al. (2009). Absence of glycochenodeoxycholic acid (GCDCA) in human bile is an indication of cholestasis: A 1H MRS study. NMR in Biomedicine, 22(5), 471–479. doi:10.1002/nbm.1355.
Jacquemin, E. (2001). Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases. Seminars in Liver Disease, 21(4), 551–562.
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007). Cancer statistics, 2007. CA: A Cancer Journal for Clinicians, 57(1), 43–66.
Kainuma, O., Asano, T., Ikehira, H., Ogawa, E. R. I., & Isono, K. (1997). Assessment of energy status and fructose metabolism of liver in obstructive jaundice by 31P magnetic resonance spectroscopy. Journal of Gastroenterology and Hepatology, 12(11), 740–744. doi:10.1111/j.1440-1746.1997.tb00362.x.
Kamisako, T., & Ogawa, H. (2005). Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis. Journal of Gastroenterology and Hepatology, 20(9), 1429–1434. doi:10.1111/j.1440-1746.2005.03950.x.
Karatepe, O., Acet, E., Battal, M., Adas, G., Altiok, M., Catay, A., et al. (2010). Effects of glutamine and curcumin on bacterial translocation in jaundiced rats. World Journal of Gastroenterology, 16(34), 4313–4320.
Khan, S. A., Cox, I. J., Thillainayagam, A. V., Bansi, D. S., Thomas, H. C., & Taylor-Robinson, S. D. (2005). Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer. European Journal of Gastroenterology and Hepatology, 17(7), 733–738.
Kharasch, N., & Thyagarajan, B. S. (1983). Structural basis for biological activities of dimethyl sulfoxide. Annals of the New York Academy of Sciences, 411, 391–402.
Kumar Srivastava, N., Pradhan, S., Mittal, B., Kumar, R., & Nagana Gowda, G. (2006). An improved, single step standardized method of lipid extraction from human skeletal muscle tissue. Analytical Letters, 39(2), 297–315.
Li, Z., Agellon, L. B., & Vance, D. E. (2005). Phosphatidylcholine homeostasis and liver failure. Journal of Biological Chemistry, 280(45), 37798–37802. doi:10.1074/jbc.M508575200.
Logrono, R., Kurtycz, D. F., Molina, C. P., Trivedi, V. A., Wong, J. Y., & Block, K. P. (2000). Analysis of false-negative diagnoses on endoscopic brush cytology of biliary and pancreatic duct strictures: the experience at 2 university hospitals. Archives of Pathology and Laboratory Medicine, 124(3), 387–392.
Man, E. B., Kartin, B. L., Durlacher, S. H., & Peters, J. P. (1945). The lipids of serum and liver in patients with hepatic diseases. The Journal of Clinical Investigation, 24(5), 623–643.
Mann, D. V., Lam, W. W. M., Hjelm, N. M., So, N. M. C., Yeung, D. K. W., Metreweli, C., et al. (2002). Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study. Gut, 50(1), 118–122. doi:10.1136/gut.50.1.118.
Mcintyre, N. (1978). Plasma lipids and lipoproteins in liver disease. Gut, 19, 526–530.
McIntyre, N., Harry, D. S., & Pearson, A. J. (1975). The hypercholesterolaemia of obstructive jaundice. Gut, 16(5), 379–391.
Menon, D. K., Sargentoni, J., Taylor-Robinson, S. D., Bell, J. D., Cox, I. J., Bryant, D. J., et al. (1995). Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology (Baltimore, MD), 21(2), 417–427.
Morgan, M. Y., Marshall, A. W., Milsom, J. P., & Sherlock, S. (1982). Plasma amino-acid patterns in liver disease. Gut, 23(5), 362–370.
Murano, T., Oyama, T., Miyashita, Y., & Shirai, K. (2008). A case of obstructive jaundice with severe hypercholesterolemia probably due to lipoprotein-Y. Journal of Atherosclerosis and Thrombosis, 15(5), 276–280.
Nagana Gowda, G., Shanaiah, N., Cooper, A., Maluccio, M., & Raftery, D. (2009). Visualization of bile homeostasis using 1H-NMR spectroscopy as a route for assessing liver cancer. Lipids, 44(1), 27–35. doi:10.1007/s11745-008-3254-6.
Nagana Gowda, G., Somashekar, B., Ijare, O., Sharma, A., Kapoor, V., & Khetrapal, C. (2006). One-step analysis of major bile components in human bile using 1H NMR spectroscopy. Lipids, 41(6), 577–589.
Naqvi, S. Q. H., Mangi, I. H., Dahri, F. J., Khaskheli, Q. A., & Akhund, A. A. (2005). Frequency of carcinoma of gall bladder in patients with cholithiasis Gomal. Journal of Medical Sciences, 3(2), 41–43.
Nicholson, J. K., Foxall, P. J. D., Spraul, M., Farrant, R. D., & Lindon, J. C. (1995). 750 MHz 1H and 1H–13C NMR spectroscopy of human blood plasma. Analytical Chemistry, 67(5), 793–811. doi:10.1021/ac00101a004.
Nishijima, T., Nishina, M., & Fujiwara, K. (1997). Measurement of lactate levels in serum and bile using proton nuclear magnetic resonance in patients with hepatobiliary diseases: Its utility in detection of malignancies. Japanese Journal of Clinical Oncology, 27(1), 13–17. doi:10.1093/jjco/27.1.13.
Notarnicola, M., Altomare, D. F., Correale, M., Ruggieri, E., D’Attoma, B., Mastrosimini, A., et al. (2005). Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases. Oncology, 68(4–6), 371–374.
Pasanen, P. A., Kauppinen, R., Eskelinen, M. J., Partanen, K. P., Pikkarainen, P. H., & Alhava, E. M. (1993). Nuclear magnetic resonance spectroscopy of plasma to distinguish between malignant and benign diseases causing jaundice and cholestasis. Journal of Cancer Research and Clinical Oncology, 119(10), 622–626.
Podo, F. (1999). Tumor Phospholipid metabolism. NMR in Biomedicine, 12, 413–439.
Simon, J. B., & Scheig, R. (1970). Serum cholesterol esterification in liver disease. New England Journal of Medicine, 283(16), 841–846. doi:10.1056/NEJM197010152831604.
Smith, A. J., van Helvoort, A., van Meer, G., Szabó, K., Welker, E., Szakács, G., et al. (2000). MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. Journal of Biological Chemistry, 275(31), 23530–23539. doi:10.1074/jbc.M909002199.
Spinelli, P., Schiavo, M., & Schicchi, A. A. (1999). L’endoscopia nella diagnosi e stadiazione del carcinoma pancreatico. Tumori, 85(1).
Starnes, H. F., Jr, Conti, P. S., Warren, R. S., Jeevanandam, M., & Brennan, M. F. (1987). Altered peripheral amino acid uptake in obstructive jaundice. The Journal of surgical research, 42(4), 383–393.
Taylor-Robinson, S. D., Thomas, E. L., Sargentoni, J., Marcus, C. D., Davidson, B. R., & Bell, J. D. (1995). Cirrhosis of the human liver: An in vitro 31P nuclear magnetic resonance study. Biochimica et Biophysica Acta, 1272(2), 113–118.
Tosi, M. R., & Tugnoli, V. (2005). Cholesteryl esters in malignancy. Clinica chimica acta; international journal of clinical chemistry, 359(1–2), 1–2.
Tripathi, P., Bala, L., Saxena, R., Yachha, S. K., Roy, R., & Khetrapal, C. L. (2009). 1H NMR spectroscopic study of blood serum for the assessment of liver function in liver transplant patients. J Gastrointestin Liver Dis, 18(3), 329–336.
Varghese, J. C., Lucey, B. C., & Soto, J. A. (2006). Imaging of biliary disorders: Cholecystitis, bile duct obstruction, stones, and stricture. In M. L. Santiago & B. C. Craig (Eds.), Evidence-based imaging optimizing imaging in patient care. New York: Springer.
Wen, H., Yoo, S. S., Kang, J., Kim, H. G., Park, J.-S., Jeong, S., et al. (2010). A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer. Journal of Hepatology, 52(2), 228–233.
Zollner, G., Marschall, H. U., Wagner, M., & Trauner, M. (2006). Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Molecular pharmaceutics, 3(3), 231–251.
Acknowledgments
The authors gratefully acknowledge Council of Scientific and Industrial Research (CSIR), New Delhi for providing fellowship to SS. Authors thank Ms. Richa Sharma, Department of Nephrology, for her fruitful suggestions during manuscript preparation. We are grateful to Dr. S. K. Mandal, bio-statistician, Centre of Biomedical Magnetic Resonance for his fruitful suggestion in multivariate statistical analysis.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Srivastava, S., Roy, R., Kumar, S. et al. Cholesterol and its esters as serum biomarkers in malignant obstructive jaundice: a single step 1H NMR metabolomic approach. Metabolomics 9, 1181–1191 (2013). https://doi.org/10.1007/s11306-013-0533-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-013-0533-x